New CDC study underscores irreplaceable role of pharmacy
and demonstrates how pharmacies can be further leveraged to meet the broader health and wellness needs of the most vulnerable Americans. In total, pharmacies have administered
Pharmacy
Dotmatics unveils Luma Lab Connect
Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced the launch of Luma™ Lab Connect, helping R&D laboratories automatically ingest data from instruments or data sources and centralize it in one place to increase accuracy and accelerate decisi
NCPA launching new leadership and business development program
ALEXANDRIA, Va. – The National Community Pharmacists Association is pleased to be announcing CORE, a revolutionary approach to training pharmacy owners and their team members on the most essential elements of team leadership.
Desperate times cue drug middlemen’s loathsome measures
Estimates project that prescription drug middlemen – pharmacy benefit managers (PBMs) – more than doubled their revenue over the course of the last decade and will do so again in the current decade.
Bayer and Dr. Reddy’s ink deal to market, distribute second brand of vericiguat in India
Dr. Reddy’s Laboratories Ltd. and Bayer have partnered to market and distribute a second brand of vericiguat in India. Under the terms of their agreement, Bayer has granted nonexclusive rights to Dr. Reddy’s under the brand name Gantra.
Suncrest Solutions announces acquisition, full integration of RxMedic ARS
PROVO, Utah – Suncrest Solutions announces the acquisition and full integration of RxMedic ARS. Rx Medix’s innovative light-up bag system is now fully integrated into Suncrest’s flagship product, the HangRx automated will-call solution.
PCMA releases statement on CMS Part D biosimilar substitution announcement
The Pharmaceutical Care Management Association (PCMA) released the following statement on the recent announcement from the Centers for Medicare and Medicaid Services (CMS) to allow Medicare Part D plans to substitute all FDA-approved biosimilars on their formularies.
NACDS hails enactment of Idaho PBM Reform Bill
signed on April 1 by Governor Brad Little (R-ID) — will help reduce prescription drug prices and preserve Idahoans’ access to pharmacies and pharmacy services. HB 596 includes important PBM reforms
VeriSIM Life announces the launch of AtlasGEN Novel Drug Designer
SAN FRANCISCO – VeriSIM Life, the leading AI-enabled R&D de-risker for breakthrough drug design and development, announced today the availability of AtlasGEN™ Novel Drug Designer.
Aurigene introduces Aurigene.AI, an artificial intelligence and machine learning assisted drug discovery platform
Aurigene Pharmaceutical Services Limited (Aurigene), a contract research, development, and manufacturing services organization and a Dr. Reddy’s Laboratories company, introduces Aurigene.
CVS expands pharmacy tuition assistance and scholarship programs
To support the next generation of pharmacists, CVS Health announced two new offerings for pharmacy students: an enhanced PharmD tuition assistance program for eligible CVS Pharmacy interns and a new scholarship for students enrolled in pharmacy schools nationwide.
Camber Pharmaceuticals launches generic Zyloprim
Camber Pharmaceuticals is pleased to announce the addition of allopurinol tablets, USP to its current portfolio. Allopurinol tablets, USP are indicated for: 1) the management of patients with signs and symptoms of primary or secondary gout.
NACDS applauds enactment of Washington State Bill holding PBMs accountable
bipartisan legislation led by State Senators Patty Kuderer (D) and Shelly Short (R) that will help protect patients’ access to pharmacies across the state. The measure was signed into law by Governor Jay Inslee
Scripius and Avera collaborate to reduce prescription costs
Scripius, a Utah-based Pharmacy Benefit Management (PBM) service, and South Dakota-based Avera, announced that Scripius will serve as the PBM for approximately 80,000 Avera Health Plans members. The cost of prescription medication is a key issue for healthcare consumers.
McKesson launches Project Oasis
IRVING, Texas – McKesson Corp. announced the launch of Project Oasis, a new initiative aimed at advancing health equity for at-risk populations in underserved communities.
CMS finalizes payment updates for 2025 Medicare Advantage and Medicare Part D Programs
The Centers for Medicare & Medicaid Services (CMS) has finalized the Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs that updates payment policies for these programs and ensures payment accuracy.